Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production
Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production Melbourne, Australia and Ajdovščina, Slovenia, 23 November 2022: Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd. (ASX:EX1), a company at the forefront of transformative medicines using exosomes,…